# Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers

> **NCT01238679** · PHASE1 · TERMINATED · sponsor: **Biogen** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-04958242
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01238679
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11-24
- **Primary completion:** 2011-05-03
- **Final completion:** 2011-05-03
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238679, "Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01238679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*